WIRB_Client-Services-photo
The most experienced and trusted provider of Biosafety solutions, the WIRB-Copernicus Group® (WCG) has evaluated over 150 human gene transfer protocols to date – more than any organization outside of the Food and Drug Administration (FDA) and the National Institute of Health (NIH). We also maintain a global presence, operating Institutional Biosafety Committees (IBCs) in the United States and Canada, as well as in eight countries in Africa, South America, Central America, the Caribbean, and Europe.
biosafety-graphicNEW

The demands for biologic safety are – and will continue to be – dynamic. Through their trusted partnership with WCG, our clients achieve the safe and successful management of research involving rDNA and other potentially hazardous biological vectors.

Our Services Include:

  • IBC Review Services
  • Biosafety Management
  • IBC and Biosafety Program Assessments
  • Biosafety Training (select agents, blood borne pathogens, IATA/DOT shipping, and customized topics)
  • Transitional Support (internal IBC administration to external IBC administration)
  • Accreditation Support (for the use of newly-approved biologic and gene therapy products)
  • Clinical Trial Protocol Development for Recombinant Materials (subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids)
Print Friendly